Susquehanna International Group’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Buy |
59,350
+6,012
| +11% | +$27.1K | ﹤0.01% | 5193 |
|
|
2025
Q1 | $247K | Buy |
53,338
+32,816
| +160% | +$152K | ﹤0.01% | 5274 |
|
|
2024
Q4 | $142K | Buy |
+20,522
| New | +$142K | ﹤0.01% | 5512 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5971 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5998 |
|
|
2024
Q1 | – | Sell |
-46,387
| Closed | -$262K | – | 5946 |
|
|
2023
Q4 | $262K | Buy |
+46,387
| New | +$262K | ﹤0.01% | 4686 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5859 |
|
|
2023
Q2 | – | Sell |
-13,111
| Closed | -$102K | – | 5977 |
|
|
2023
Q1 | $102K | Buy |
+13,111
| New | +$102K | ﹤0.01% | 5244 |
|
|
2022
Q4 | – | Sell |
-18,916
| Closed | -$155K | – | 6203 |
|
|
2022
Q3 | $155K | Sell |
18,916
-7,498
| -28% | -$61.4K | ﹤0.01% | 4984 |
|
|
2022
Q2 | $255K | Buy |
+26,414
| New | +$255K | ﹤0.01% | 4216 |
|